HINDUSTAN AGRIGENETICS LTD.

Hindustan Agrigenetics Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in accordance with the company's 'Code of Conduct for Prevention of Insider Trading' and SEBI regulations. The window will remain shut from July 1, 2026, until 48 hours after the declaration of the un-audited financial results for the quarter ended June 30, 2026. The specific date for the board meeting to approve these results will be communicated separately.

Hindustan Agrigenetics Ltd's board approved the audited standalone financial results for the quarter and year ended March 31, 2026. The company reported a total revenue of ₹43.36 Lacs for the year ended March 31, 2026, compared to ₹17.92 Lacs for the year ended March 31, 2025. The company reported a loss before tax of ₹27.68 Lacs for the year ended March 31, 2026, compared to a loss of ₹51.88 Lacs for the year ended March 31, 2025. Additionally, Mr. V. R. Sridharan, Chartered Accountant, was appointed as the Internal Auditor for FY 2026-27.

Hindustan Agrigenetics Ltd has appointed Mr. V. R. Sridharan, a Chartered Accountant, as the Internal Auditor for the financial year 2026-27. This decision was approved during the Board of Directors meeting held on May 30, 2026, where the audited financial results for the quarter and year ended March 31, 2026, were also approved. The company has enclosed a brief profile of Mr. Sridharan as per SEBI circular guidelines.

Hindustan Agrigenetics Ltd. has announced that it did not raise any funds through Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement (QIP), or any other issue during the quarter ended March 31, 2026. Consequently, the requirement to submit a statement of deviation(s) or variation(s) in the utilization of funds under Regulation 32 of the SEBI (LODR) Regulations, 2015 is not applicable to the company for the specified quarter.

Hindustan Agrigenetics Ltd's Board approved audited financial results for the quarter and year ended March 31, 2026. The company reported total revenue of ₹105.15 Lacs and a loss before tax of ₹27.68 Lacs. The board also approved the appointment of Mr. V. R. Sridharan as Internal Auditor for the F.Y. 2026-27.

Hindustan Agrigenetics Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2026. The trading window remains closed for insiders until 48 hours after the results are approved and filed.

Hindustan Agrigenetics Ltd, with the scrip code 519574, has released the yearly disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 2011 from its promoters and promoter group for the year ended on 31st March, 2026. Rajendra Naniwadekar, the Promoter holding shares of the company, has declared and confirmed that neither the Promoter nor the promoter group members have made any encumbrance, directly or indirectly, over the shares of the company during the financial year ended 31.3.2026.

Hindustan Agrigenetics Ltd has announced the closure of its trading window for designated persons and their immediate relatives, as per the company's 'Code of Conduct for Prevention of Insider Trading'. The closure will be effective from Wednesday, April 1, 2026, and will remain in force until 48 hours after the declaration of the Audited Financial Results (Standalone & Consolidated) for the quarter and year ended March 31, 2026. The date of the Board meeting for considering the Audited Financial Results will be informed to the Exchanges in due course.

Hindustan Agrigenetics Ltd has corrected an error in the name of its recently appointed Chief Financial Officer (CFO). The correct name of the appointee is Mr. Suresh Srinivasan, not 'Sursh Srinivasan' as previously mentioned in the intimation dated 14th March, 2026. The company clarifies that all other details provided in the earlier intimation remain unchanged.

Hindustan Agrigenetics Ltd has appointed Mr. Sursh Srinivasan as the Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the company. The appointment was approved by the Board of Directors in a meeting held on 14th March 2026, based on the recommendation of the Nomination and Remuneration Committee and Audit Committee. Mr. Srinivasan, a finance professional with extensive experience, will assume his role from 16th March 2026.